Two broad-spectrum antibiotics, ampicillin and metronidazole, have little impact on bifıdobacteria growing in cultures containing mixed bacterial populations, suggesting that probiotics containing those bacteria might stabilize the gut microbiota during and following antibiotic treatments of the host, according to George and Sandra MacFarlane and their collaborators at the University of Dundee in Dundee, United Kingdom (UK). Their article was published ahead of print in Antimicrobial Agents and Chemotherapy on February 12, 2013 (doi: 10.1128/ AAC.00079-13) .
Both of those antibiotics reduce levels of Bacteroides bacteria in mixed cultures that resemble but greatly simplify those involving the gut microbiota. However, ampicillin affected only some of the bifıdobacterial species, and only while they were being grown with low nutrients, according to Sandra MacFarlane. Although antibiotics disrupt many species within mixed microbial populations and alter their metabolic products, the resilience of the bifıdobacteria component within such culture-grown populations points to their potential as probiotic therapy for patients undergoing antibiotic treatments, she says.
These bacterial growth studies involved a "continuous culture colonic model," MacFarlane says. Compared to experiments with animals, this in vitro system simplifıes efforts to test the effects of antibiotics and other environmental agents on mixed microbial populations and their metabolism, she points out. Nutrients are fed into one end of a vessel containing in this case 14 bacterial species, and waste materials are removed from the other end of the vessel. Those 14 species were chosen "to represent different microbial communities occupying diverse nutritional niches within the intestinal microbiota," she and her collaborators note.
"The approach used is a refreshing change from studies that attempt to characterize microbial complexity, which is often very challenging, even with modern analytical techniques," says Andrew McBain of the University of Manchester in Manchester, UK. "By complexity I mean microbial composition, metabolic activities at the cellular and community level, physical and metabolic relationships between organisms, growth on surfaces, and metabolic interaction between bacterium and host."
The model was "not intended to simulate the human colon but [was] employed to investigate ecological and physiological interactions between specifıc groups of bacteria under strict, environmentally controlled conditions," note the members of the Dundee research group. The sheer complexity of the colonic microbiota can stymie efforts to determine exactly what is causing changes in physiology and metabolism of individual bacterial species when antibiotics are applied, in relation to other environmental influences, such as availability of nutrients and gut transit times.
"Realistically, this work is several steps away from a direct impact on society," McBain says. "Ultimately, any therapies that could reduce the incidence or severity of antibiotic-associated diarrhea would save many lives and reduce a great deal of suffering." Chinese health officials confirm a slow but continuing outbreak of H7N9 influenza viral infections, affecting more than 131 patients by early May with at least 32 deaths, according to the World Health Organization (WHO). "There is no evidence of ongoing human-to-human transmission," WHO officials note. The first human cases were reported at the end of March. An early genetic analysis indicates that the "human isolates, but not the avian and environmental ones, have a protein mutation that allows for efficient growth in human cells and that also allows them to grow at a temperature that corresponds to the upper respiratory tract of humans, which is lower than you find in birds," report Masato Tashiro 
